Search
Close this search box.

NIIMBL News

Search news

Posted 10/17/2023

NIIMBL Is Now Accepting Applications for the 2024 NIIMBL eXperience Cohort

Newark, Del., October 17, 2023 – The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has awarded approximately $500k in funding to launch the 2024 NIIMBL eXperience program in
Posted 10/10/2023

NIIMBL Launches Viral Vector Program to Improve Access to AAV Gene Therapy

NEWARK, Del., October 10, 2023 — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) officially launches the Viral Vectors NIIMBL-led Program focused on developing and making broadly
Posted 09/12/2023

NIIMBL awards $370K for 5 eXperience programs in 2024

NIIMBL is pleased to announce it has awarded $370K to launch five NIIMBL eXperience programs next summer. These host locations represent distinct regions across the country. Each location
Posted 08/10/2023

NIIMBL Announces RFI for Next-Generation Sequencing Method Development Study

NEWARK, Del., August 10, 2023 — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce a Request for Information (RFI) related to a planned
Posted 06/08/2023

NIIMBL Announces New Funding Opportunities

NEWARK, Del., June 8, 2023 — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce approximately $4M in funding through Project Call (PC) 7.1
Posted 04/25/2023

NIIMBL Selects Largest eXperience Program Cohort to Date

Newark, Del., April 25, 2023 – The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has announced the selection of 44 college freshman and sophomores to participate in the

Become a member

We offer a variety of membership options that give you the flexibility to choose your organization’s level of engagement based on technology interests and priorities.

Join Our Mailing List

MailChimp NIIMBL Mailing List Signup
Organization Type
How did you first hear about NIIMBL?